Cano Health (CANO) Stock Forecast, Price Target & Predictions
CANO Stock Forecast
Cano Health stock forecast is as follows: an average price target of $6.42 (represents a 1505.00% upside from CANO’s last price of $0.40) and a rating consensus of 'Buy', based on 3 wall street analysts offering a 1-year stock forecast.
CANO Price Target
CANO Analyst Ratings
Buy
Cano Health Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Jan 06, 2023 | UBS | - | - | 13.64% | 212.50% | |
Nov 16, 2022 | Citigroup | - | - | 144.79% | 1150.00% | |
May 10, 2022 | Jason Cassorla | Citigroup | - | - | 93.94% | 1900.00% |
Apr 20, 2022 | UBS | - | - | 190.70% | 3650.00% | |
Mar 18, 2022 | Gary Taylor | Cowen & Co. | - | - | 85.98% | 3150.00% |
Jan 14, 2022 | Jason Cassorla | Citigroup | - | - | 84.33% | 2900.00% |
10
Cano Health Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | - | - |
Avg Price Target | - | - | - |
Last Closing Price | $0.40 | $0.40 | $0.40 |
Upside/Downside | -100.00% | -100.00% | -100.00% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Jan 06, 2023 | UBS | Neutral | Downgrade | |
Nov 16, 2022 | Citigroup | Buy | Buy | Hold |
Jun 24, 2022 | Raymond James | Outperform | Initialise | |
May 10, 2022 | Citigroup | Buy | Buy | Hold |
10
Cano Health Financial Forecast
Cano Health Revenue Forecast
Quarter
Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Mar 22 | Sep 21 | Jun 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | $788.07M | $766.75M | $866.91M | $704.34M | $526.80M | $393.16M |
Avg Forecast | $1.73B | $1.53B | $1.34B | $710.55M | $759.84M | $828.43M | $826.34M | $666.03M | $435.67M | $306.85M |
High Forecast | $1.76B | $1.57B | $1.37B | $711.00M | $772.00M | $845.87M | $843.74M | $680.06M | $444.84M | $313.31M |
Low Forecast | $1.71B | $1.52B | $1.33B | $710.10M | $742.40M | $820.37M | $818.30M | $659.55M | $431.43M | $303.86M |
# Analysts | - | - | 1 | 2 | 3 | 1 | 1 | 1 | 1 | 1 |
Surprise % | - | - | - | - | 1.04% | 0.93% | 1.05% | 1.06% | 1.21% | 1.28% |
Forecast
Cano Health EBITDA Forecast
Quarter
Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Mar 22 | Sep 21 | Jun 21 | |
---|---|---|---|---|---|---|---|---|---|---|
# Analysts | - | - | 1 | 2 | 3 | 1 | 1 | 1 | 1 | 1 |
EBITDA | - | - | - | - | $-65.86M | $-142.09M | $-5.88M | $11.29M | $-33.60M | $25.12M |
Avg Forecast | $38.65M | $34.35M | $30.06M | $15.92M | $17.02M | $18.56M | $18.51M | $27.79M | $-36.96M | $6.87M |
High Forecast | $39.46M | $35.08M | $30.69M | $15.93M | $17.29M | $18.95M | $18.90M | $33.35M | $-29.57M | $7.02M |
Low Forecast | $38.27M | $34.02M | $29.77M | $15.91M | $16.63M | $18.38M | $18.33M | $22.23M | $-44.36M | $6.81M |
Surprise % | - | - | - | - | -3.87% | -7.66% | -0.32% | 0.41% | 0.91% | 3.65% |
Forecast
Cano Health Net Income Forecast
Quarter
Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Mar 22 | Sep 21 | Jun 21 | |
---|---|---|---|---|---|---|---|---|---|---|
# Analysts | - | - | 1 | 2 | 3 | 1 | 1 | 1 | 1 | 1 |
Net Income | - | - | - | - | $-260.49M | $-140.75M | $-28.15M | $-85.00K | $-67.13M | $9.48M |
Avg Forecast | $813.63M | $708.69M | $832.13M | $-100.29M | $-121.41M | $-47.51M | $-73.90M | $1.22M | $-73.84M | $-38.71M |
High Forecast | $25.13B | $21.89B | $25.70B | $-5.81B | $-7.39B | $-1.47B | $-2.28B | $1.46M | $-59.07M | $-1.20B |
Low Forecast | $43.42B | $37.82B | $44.40B | $-10.03B | $-12.14B | $-2.53B | $-3.94B | $975.52K | $-88.61M | $-2.07B |
Surprise % | - | - | - | - | 2.15% | 2.96% | 0.38% | -0.07% | 0.91% | -0.24% |
Forecast
Cano Health SG&A Forecast
Quarter
Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Mar 22 | Sep 21 | Jun 21 | |
---|---|---|---|---|---|---|---|---|---|---|
# Analysts | - | - | 1 | 2 | 3 | 1 | 1 | 1 | 1 | 1 |
SG&A | - | - | - | - | $80.82M | $99.42M | $96.47M | $96.59M | $75.93M | $46.57M |
Avg Forecast | $258.60M | $229.87M | $201.13M | $106.51M | $113.90M | $124.18M | $123.87M | $178.45M | $83.52M | $46.00M |
High Forecast | $264.05M | $234.71M | $205.37M | $106.58M | $115.72M | $126.79M | $126.48M | $214.14M | $100.22M | $46.96M |
Low Forecast | $256.08M | $227.63M | $199.18M | $106.44M | $111.28M | $122.97M | $122.66M | $142.76M | $66.81M | $45.55M |
Surprise % | - | - | - | - | 0.71% | 0.80% | 0.78% | 0.54% | 0.91% | 1.01% |
Forecast
Cano Health EPS Forecast
Quarter
Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Mar 22 | Sep 21 | Jun 21 | |
---|---|---|---|---|---|---|---|---|---|---|
# Analysts | - | - | 1 | 2 | 3 | 1 | 1 | 1 | 1 | 1 |
EPS | - | - | - | - | $-91.87 | $-0.00 | $-0.12 | $-0.00 | $-0.09 | $0.06 |
Avg Forecast | $1.54 | $1.34 | $1.58 | $-0.19 | $-0.23 | $-0.09 | $-0.14 | $-0.10 | $-0.00 | $-0.07 |
High Forecast | $47.61 | $41.47 | $48.69 | $-11.00 | $-14.00 | $-2.78 | $-4.32 | $-3.09 | $-0.05 | $-2.27 |
Low Forecast | $82.25 | $71.64 | $84.12 | $-19.00 | $-23.00 | $-4.80 | $-7.47 | $-5.34 | $-0.08 | $-3.91 |
Surprise % | - | - | - | - | 399.43% | 0.01% | 0.86% | 0.00% | 59.60% | -0.82% |
Forecast
Cano Health Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
TOI | Oncology Institute | - | - | 5233.33% | Buy |
CANO | Cano Health | - | - | 179.13% | Buy |
AGL | agilon health | - | - | 132.80% | Buy |
ACHC | Acadia Healthcare Company | - | - | 115.35% | Buy |
INNV | InnovAge | - | - | 39.06% | Hold |
BKD | Brookdale Senior Living | - | - | 36.86% | Buy |
EHAB | Enhabit | - | - | 35.58% | Hold |
AMEH | Astrana Health | - | - | 18.81% | Buy |
PNTG | Pennant Group | - | - | 11.34% | Buy |
UHS | Universal Health Services | - | - | 5.32% | Hold |
ENSG | Ensign Group | - | - | 1.26% | Buy |
SEM | Select Medical | - | - | 0.83% | Buy |
THC | Tenet Healthcare | - | - | -10.46% | Buy |